AXP American Express | $320.87
-1.5% | 1/24/2025 | Target Raised by | BTIG Research | Analyst V. Caintic | Sell -> Sell | $266.00 -> $270.00 | High | View details for BTIG Research rating of American Express (NYSE:AXP) on 1/24/2025 |
PLD Prologis | $118.90
+0.3% | 1/17/2025 | Target Lowered by | BTIG Research | - | Buy -> Buy | $154.00 -> $134.00 | Medium | View details for BTIG Research rating of Prologis (NYSE:PLD) on 1/17/2025 |
MTCH Match Group | $34.06
+2.4% | 1/14/2025 | Downgraded by | BTIG Research | Analyst J. Fuller | Buy -> Neutral | | Medium | View details for BTIG Research rating of Match Group (NASDAQ:MTCH) on 1/14/2025 |
CART Maplebear | $45.99
+1.2% | 1/14/2025 | Upgraded by | BTIG Research | Analyst J. Fuller | Neutral -> Buy | $58.00 | Medium | View details for BTIG Research rating of Maplebear (NASDAQ:CART) on 1/14/2025 |
BOOT Boot Barn | $169.13
+0.4% | 1/13/2025 | Target Raised by | BTIG Research | Analyst Janine Stichter | Buy -> Buy | $185.00 -> $190.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 1/13/2025 |
IBRX ImmunityBio | $3.17
+1.6% | 1/10/2025 | Initiated by | BTIG Research | Analyst J. Zelin | Buy | $6.00 | High | View details for BTIG Research rating of ImmunityBio (NASDAQ:IBRX) on 1/10/2025 |
NARI Inari Medical | $79.74
+0.4% | 1/8/2025 | Reiterated by | BTIG Research | Analyst M. Thibault | Buy -> Neutral | | Low | View details for BTIG Research rating of Inari Medical (NASDAQ:NARI) on 1/8/2025 |
PANW Palo Alto Networks | $187.70
+0.2% | 1/8/2025 | Downgraded by | BTIG Research | Analyst G. Powell | Buy -> Neutral | | Medium | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 1/8/2025 |
HIMS Hims & Hers Health | $30.89
0.0% | 1/7/2025 | Initiated by | BTIG Research | Analyst D. Larsen | Buy | $35.00 | Medium | View details for BTIG Research rating of Hims & Hers Health (NYSE:HIMS) on 1/7/2025 |
VSTM Verastem | $5.92
+5.9% | 12/31/2024 | Target Raised by | BTIG Research | - | Buy | $13.00 -> $20.00 | N/A | View details for BTIG Research rating of Verastem (NASDAQ:VSTM) on 12/31/2024 |
|
FTAI FTAI Aviation | $90.98
-10.4% | 12/31/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $180.00 -> $190.00 | N/A | View details for BTIG Research rating of FTAI Aviation (NYSE:FTAI) on 12/31/2024 |
SDA SunCar Technology Group | $9.54
+0.8% | 12/30/2024 | Initiated by | BTIG Research | Analyst M. Fong | Buy | $12.00 | N/A | View details for BTIG Research rating of SunCar Technology Group (NASDAQ:SDA) on 12/30/2024 |
IIPR Innovative Industrial Properties | $68.12
+1.2% | 12/23/2024 | Downgraded by | BTIG Research | Analyst T. Catherwood | Buy -> Neutral | | N/A | View details for BTIG Research rating of Innovative Industrial Properties (NYSE:IIPR) on 12/23/2024 |
IREN Iris Energy | $13.32
+8.5% | 12/20/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $33.00 | N/A | View details for BTIG Research rating of Iris Energy (NASDAQ:IREN) on 12/20/2024 |
LEN Lennar | $132.40
-1.6% | 12/20/2024 | Downgraded by | BTIG Research | Analyst C. Reichardt | Buy -> Neutral | | N/A | View details for BTIG Research rating of Lennar (NYSE:LEN) on 12/20/2024 |
FREY FREYR Battery | $1.98
-5.5% | 12/20/2024 | Upgraded by | BTIG Research | Analyst G. Lewis | Neutral -> Buy | $4.00 | N/A | View details for BTIG Research rating of FREYR Battery (NYSE:FREY) on 12/20/2024 |
AVTX Avalo Therapeutics | $7.54
-0.5% | 12/19/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $40.00 | N/A | View details for BTIG Research rating of Avalo Therapeutics (NASDAQ:AVTX) on 12/19/2024 |
RNAC Cartesian Therapeutics | $19.20
-1.1% | 12/19/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $42.00 | N/A | View details for BTIG Research rating of Cartesian Therapeutics (NASDAQ:RNAC) on 12/19/2024 |
BIRK Birkenstock | $59.83
+2.0% | 12/18/2024 | Target Raised by | BTIG Research | Analyst J. Stichter | Buy | $60.00 -> $70.00 | N/A | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 12/18/2024 |
ADPT Adaptive Biotechnologies | $7.99
-1.7% | 12/18/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $8.00 -> $9.00 | N/A | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 12/18/2024 |
REAX Real Brokerage | $4.77
+0.4% | 12/18/2024 | Initiated by | BTIG Research | Analyst J. Fuller | Buy | $6.00 | N/A | View details for BTIG Research rating of Real Brokerage (NASDAQ:REAX) on 12/18/2024 |
GTLS Chart Industries | $218.41
+1.1% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $170.00 -> $210.00 | N/A | View details for BTIG Research rating of Chart Industries (NYSE:GTLS) on 12/16/2024 |
BE Bloom Energy | $29.65
+7.2% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $30.00 | N/A | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 12/16/2024 |
CORZ Core Scientific | $15.98
-2.2% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $19.00 -> $20.00 | N/A | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 12/16/2024 |
GAMB Gambling.com Group | $14.61
+1.5% | 12/13/2024 | Target Raised by | BTIG Research | - | Buy | $13.00 -> $19.00 | N/A | View details for BTIG Research rating of Gambling.com Group (NASDAQ:GAMB) on 12/13/2024 |
ELVN Enliven Therapeutics | $21.86
-0.8% | 12/13/2024 | Initiated by | BTIG Research | Analyst J. Zelin | Buy | $42.00 | N/A | View details for BTIG Research rating of Enliven Therapeutics (NASDAQ:ELVN) on 12/13/2024 |
AXDX Accelerate Diagnostics | $1.17
+1.7% | 12/11/2024 | Upgraded by | BTIG Research | Analyst M. Massaro | Strong-Buy | | N/A | View details for BTIG Research rating of Accelerate Diagnostics (NASDAQ:AXDX) on 12/11/2024 |
GMED Globus Medical | $92.82
+0.4% | 12/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $87.00 -> $91.00 | N/A | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 12/12/2024 |
KROS Keros Therapeutics | $11.84
-1.5% | 12/12/2024 | Downgraded by | BTIG Research | Analyst J. Harrison | Buy -> Neutral | | N/A | View details for BTIG Research rating of Keros Therapeutics (NASDAQ:KROS) on 12/12/2024 |
AVDX AvidXchange | $10.51
+0.9% | 12/11/2024 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $14.00 | N/A | View details for BTIG Research rating of AvidXchange (NASDAQ:AVDX) on 12/11/2024 |
NRIX Nurix Therapeutics | $19.93
-0.2% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $35.00 | N/A | View details for BTIG Research rating of Nurix Therapeutics (NASDAQ:NRIX) on 12/10/2024 |
KYMR Kymera Therapeutics | $44.36
+0.3% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $60.00 | N/A | View details for BTIG Research rating of Kymera Therapeutics (NASDAQ:KYMR) on 12/10/2024 |
ARVN Arvinas | $18.14
+0.8% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $69.00 | N/A | View details for BTIG Research rating of Arvinas (NASDAQ:ARVN) on 12/10/2024 |
CARM Carisma Therapeutics | $0.48
+7.7% | 12/10/2024 | Downgraded by | BTIG Research | Analyst J. Zelin | Buy -> Neutral | | N/A | View details for BTIG Research rating of Carisma Therapeutics (NASDAQ:CARM) on 12/10/2024 |
ONIT Onity Group | $35.34
-0.3% | 12/9/2024 | Upgraded by | BTIG Research | Analyst E. Hagen | Neutral -> Buy | $40.00 | N/A | View details for BTIG Research rating of Onity Group (NYSE:ONIT) on 12/9/2024 |
OKTA Okta | $88.86
+0.9% | 12/4/2024 | Target Raised by | BTIG Research | - | Buy | $98.00 -> $110.00 | N/A | View details for BTIG Research rating of Okta (NASDAQ:OKTA) on 12/4/2024 |
JANX Janux Therapeutics | $44.11
-1.1% | 12/3/2024 | Target Raised by | BTIG Research | - | Buy | $82.00 -> $100.00 | N/A | View details for BTIG Research rating of Janux Therapeutics (NASDAQ:JANX) on 12/3/2024 |
EVH Evolent Health | $10.11
-0.7% | 12/3/2024 | Target Lowered by | BTIG Research | - | Buy | $36.00 -> $29.00 | N/A | View details for BTIG Research rating of Evolent Health (NYSE:EVH) on 12/3/2024 |
BV BrightView | $15.59
-1.0% | 12/2/2024 | Initiated by | BTIG Research | Analyst C. Reichardt | Buy | $22.00 | N/A | View details for BTIG Research rating of BrightView (NYSE:BV) on 12/2/2024 |
ANAB AnaptysBio | $16.85
+1.3% | 12/2/2024 | Downgraded by | BTIG Research | Analyst J. Harrison | Buy -> Neutral | | N/A | View details for BTIG Research rating of AnaptysBio (NASDAQ:ANAB) on 12/2/2024 |
Must-See: 5-Second Trump Prediction (Ad) President Trump's prediction is about to become a reality...
Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration. Click here now to get the details because you must act before January 20th. |
OTLK Outlook Therapeutics | $1.99
-2.5% | 11/29/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $50.00 -> $9.00 | N/A | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 11/29/2024 |
REG Regency Centers | $71.77
+1.0% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $72.00 -> $79.00 | N/A | View details for BTIG Research rating of Regency Centers (NASDAQ:REG) on 11/27/2024 |
CDP COPT Defense Properties | $29.84
+0.8% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $33.00 -> $38.00 | N/A | View details for BTIG Research rating of COPT Defense Properties (NYSE:CDP) on 11/27/2024 |
ADC Agree Realty | $71.84
+0.5% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $74.00 -> $78.00 | N/A | View details for BTIG Research rating of Agree Realty (NYSE:ADC) on 11/27/2024 |
ZS Zscaler | $193.47
+0.4% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $205.00 -> $238.00 | N/A | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 11/27/2024 |
PNST Pinstripes | $0.39
+1.6% | 11/27/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $4.00 -> $3.00 | N/A | View details for BTIG Research rating of Pinstripes (NYSE:PNST) on 11/27/2024 |
EMBC Embecta | $18.96
-0.9% | 11/27/2024 | Upgraded by | BTIG Research | Analyst M. Thibault | Neutral -> Buy | $26.00 | N/A | View details for BTIG Research rating of Embecta (NASDAQ:EMBC) on 11/27/2024 |
ALC Alcon | $89.02
-0.1% | 11/26/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Strong-Buy -> Hold | | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 11/26/2024 |
ALEC Alector | $1.79
-1.1% | 11/26/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $16.00 -> $5.00 | N/A | View details for BTIG Research rating of Alector (NASDAQ:ALEC) on 11/26/2024 |
PSTX Poseida Therapeutics | $9.50
| 11/26/2024 | Reiterated by | BTIG Research | Analyst J. Zelin | Buy -> Neutral | | N/A | View details for BTIG Research rating of Poseida Therapeutics (NASDAQ:PSTX) on 11/26/2024 |
ISRG Intuitive Surgical | $584.05
-4.0% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $535.00 -> $561.00 | N/A | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 11/26/2024 |
GKOS Glaukos | $160.50
-0.4% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $140.00 -> $149.00 | N/A | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 11/26/2024 |
PEN Penumbra | $274.25
+0.2% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $232.00 -> $270.00 | N/A | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 11/26/2024 |
VCEL Vericel | $57.43
+0.0% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $56.00 -> $66.00 | N/A | View details for BTIG Research rating of Vericel (NASDAQ:VCEL) on 11/26/2024 |
EXAS Exact Sciences | $55.98
+1.5% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $75.00 | N/A | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 11/26/2024 |
VVX V2X | $53.08
-1.1% | 11/25/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $80.00 | N/A | View details for BTIG Research rating of V2X (NYSE:VVX) on 11/25/2024 |
PANW Palo Alto Networks | $187.70
+0.2% | 11/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $197.50 -> $207.00 | N/A | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 11/21/2024 |
MSTR MicroStrategy | $353.67
-5.2% | 11/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $290.00 -> $570.00 | N/A | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 11/21/2024 |
ACRS Aclaris Therapeutics | $2.51
-1.6% | 11/19/2024 | Upgraded by | BTIG Research | Analyst J. Harrison | Neutral -> Buy | $8.00 | N/A | View details for BTIG Research rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/19/2024 |
VYNE VYNE Therapeutics | $2.76
+3.4% | 11/18/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $8.00 | N/A | View details for BTIG Research rating of VYNE Therapeutics (NASDAQ:VYNE) on 11/18/2024 |
BE Bloom Energy | $29.65
+7.2% | 11/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $16.00 -> $20.00 | N/A | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 11/15/2024 |
CIFR Cipher Mining | $5.90
+6.7% | 11/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $6.00 -> $9.00 | N/A | View details for BTIG Research rating of Cipher Mining (NASDAQ:CIFR) on 11/15/2024 |
CORZ Core Scientific | $15.98
-2.2% | 11/15/2024 | Target Raised by | BTIG Research | Analyst G. Lewis | Buy -> Buy | $15.00 -> $19.00 | N/A | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 11/15/2024 |
HQY HealthEquity | $106.88
+2.1% | 11/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $130.00 | N/A | View details for BTIG Research rating of HealthEquity (NASDAQ:HQY) on 11/14/2024 |
PLUG Plug Power | $2.08
-0.5% | 11/14/2024 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | N/A | View details for BTIG Research rating of Plug Power (NASDAQ:PLUG) on 11/14/2024 |
ONON ON | $60.21
-0.4% | 11/13/2024 | Upgraded by | BTIG Research | Analyst J. Stichter | Neutral -> Buy | $64.00 | N/A | View details for BTIG Research rating of ON (NYSE:ONON) on 11/13/2024 |
ATLC Atlanticus | $57.10
-2.1% | 11/12/2024 | Target Raised by | BTIG Research | Analyst V. Caintic | Buy -> Buy | $45.00 -> $54.00 | N/A | View details for BTIG Research rating of Atlanticus (NASDAQ:ATLC) on 11/12/2024 |
VEL Velocity Financial | $18.40
-0.1% | 11/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $23.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 11/12/2024 |
CCSI Consensus Cloud Solutions | $26.36
+2.1% | 11/11/2024 | Target Raised by | BTIG Research | Analyst D. Larsen | Buy -> Buy | $30.00 -> $32.00 | N/A | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 11/11/2024 |
FLUT Flutter Entertainment | $267.27
-0.2% | 11/11/2024 | Target Raised by | BTIG Research | Analyst C. Lampen | Buy -> Buy | $249.00 -> $305.00 | N/A | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 11/11/2024 |
UPST Upstart | $67.44
-2.7% | 11/11/2024 | Upgraded by | BTIG Research | Analyst V. Caintic | Sell -> Neutral | | N/A | View details for BTIG Research rating of Upstart (NASDAQ:UPST) on 11/11/2024 |
EXPE Expedia Group | $171.23
-3.2% | 11/8/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $175.00 -> $200.00 | N/A | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 11/8/2024 |
PODD Insulet | $280.35
+1.1% | 11/8/2024 | Target Raised by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $260.00 -> $270.00 | N/A | View details for BTIG Research rating of Insulet (NASDAQ:PODD) on 11/8/2024 |
APP AppLovin | $363.10
+0.2% | 11/7/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $202.00 -> $291.00 | N/A | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 11/7/2024 |
UPWK Upwork | $16.26
+3.6% | 11/7/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $14.00 -> $16.00 | N/A | View details for BTIG Research rating of Upwork (NASDAQ:UPWK) on 11/7/2024 |
MELI MercadoLibre | $1,843.45
+0.8% | 11/7/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $2,250.00 -> $2,200.00 | N/A | View details for BTIG Research rating of MercadoLibre (NASDAQ:MELI) on 11/7/2024 |
RVLV Revolve Group | $31.54
+0.3% | 11/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $30.00 -> $35.00 | N/A | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 11/6/2024 |
EXAS Exact Sciences | $55.98
+1.5% | 11/6/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $82.00 -> $65.00 | N/A | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 11/6/2024 |
CDNA CareDx | $22.34
-4.7% | 11/5/2024 | Target Lowered by | BTIG Research | Analyst M. Massaro | Buy -> Buy | $40.00 -> $35.00 | Low | View details for BTIG Research rating of CareDx (NASDAQ:CDNA) on 11/5/2024 |
TCMD Tactile Systems Technology | $17.39
+0.2% | 11/5/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Buy -> Neutral | | High | View details for BTIG Research rating of Tactile Systems Technology (NASDAQ:TCMD) on 11/5/2024 |
FVRR Fiverr International | $31.13
-1.2% | 11/4/2024 | Downgraded by | BTIG Research | Analyst M. Fong | Buy -> Neutral | | Medium | View details for BTIG Research rating of Fiverr International (NYSE:FVRR) on 11/4/2024 |
WRBY Warby Parker | $25.98
-1.0% | 11/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $20.00 | Low | View details for BTIG Research rating of Warby Parker (NYSE:WRBY) on 11/1/2024 |
IQV IQVIA | $204.54
-0.7% | 11/1/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $290.00 -> $260.00 | Low | View details for BTIG Research rating of IQVIA (NYSE:IQV) on 11/1/2024 |
RBLX Roblox | $67.00
-0.2% | 11/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $51.00 -> $56.00 | Low | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 11/1/2024 |
WING Wingstop | $279.83
-3.0% | 10/31/2024 | Upgraded by | BTIG Research | Analyst P. Saleh | Neutral -> Buy | $370.00 | Medium | View details for BTIG Research rating of Wingstop (NASDAQ:WING) on 10/31/2024 |
APP AppLovin | $363.10
+0.2% | 10/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $202.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 10/30/2024 |
SYK Stryker | $394.08
+0.1% | 10/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $383.00 -> $394.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 10/30/2024 |
TTD Trade Desk | $119.96
+0.7% | 10/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $114.00 -> $142.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 10/30/2024 |
DHI D.R. Horton | $142.98
-1.6% | 10/30/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $190.00 -> $186.00 | Low | View details for BTIG Research rating of D.R. Horton (NYSE:DHI) on 10/30/2024 |
AGYS Agilysys | $92.24
-3.6% | 10/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $118.00 -> $124.00 | High | View details for BTIG Research rating of Agilysys (NASDAQ:AGYS) on 10/29/2024 |
Must-See: 5-Second Trump Prediction (Ad) President Trump's prediction is about to become a reality...
Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration. Click here now to get the details because you must act before January 20th. |
BOOT Boot Barn | $169.13
+0.4% | 10/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $165.00 -> $185.00 | High | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 10/29/2024 |
NESR National Energy Services Reunited | $9.52
+0.7% | 10/25/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $15.00 | Medium | View details for BTIG Research rating of National Energy Services Reunited (NASDAQ:NESR) on 10/25/2024 |
TMHC Taylor Morrison Home | $65.47
-1.0% | 10/24/2024 | Target Raised by | BTIG Research | Analyst C. Reichardt | Buy -> Buy | $78.00 -> $86.00 | Low | View details for BTIG Research rating of Taylor Morrison Home (NYSE:TMHC) on 10/24/2024 |
SLP Simulations Plus | $33.78
+0.8% | 10/24/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $60.00 -> $50.00 | High | View details for BTIG Research rating of Simulations Plus (NASDAQ:SLP) on 10/24/2024 |
HLX Helix Energy Solutions Group | $8.54
-2.2% | 10/24/2024 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | High | View details for BTIG Research rating of Helix Energy Solutions Group (NYSE:HLX) on 10/24/2024 |
DT Dynatrace | $55.64
+1.6% | 10/23/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $57.00 -> $63.00 | Low | View details for BTIG Research rating of Dynatrace (NYSE:DT) on 10/23/2024 |
ENVA Enova International | $111.67
+0.4% | 10/23/2024 | Target Raised by | BTIG Research | Analyst V. Caintic | Buy -> Buy | $90.00 -> $110.00 | High | View details for BTIG Research rating of Enova International (NYSE:ENVA) on 10/23/2024 |
PHM PulteGroup | $115.66
-0.7% | 10/23/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $139.00 -> $156.00 | Low | View details for BTIG Research rating of PulteGroup (NYSE:PHM) on 10/23/2024 |
CARG CarGurus | $38.93
-1.0% | 10/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $30.00 -> $35.00 | Low | View details for BTIG Research rating of CarGurus (NASDAQ:CARG) on 10/22/2024 |
TRUE TrueCar | $3.62
+2.3% | 10/22/2024 | Target Raised by | BTIG Research | Analyst M. Fong | Buy -> Buy | $3.75 -> $4.50 | Low | View details for BTIG Research rating of TrueCar (NASDAQ:TRUE) on 10/22/2024 |
DECK Deckers Outdoor | $216.90
-0.8% | 10/22/2024 | Downgraded by | BTIG Research | Analyst J. Stichter | Buy -> Neutral | | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 10/22/2024 |
MSTR MicroStrategy | $353.67
-5.2% | 10/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $180.00 -> $240.00 | Medium | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 10/21/2024 |
ISRG Intuitive Surgical | $584.05
-4.0% | 10/18/2024 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | | $535.00 | Medium | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 10/18/2024 |
BIRK Birkenstock | $59.83
+2.0% | 10/18/2024 | Target Set by | BTIG Research | Analyst J. Stichter | Buy -> Buy | $60.00 | Low | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 10/18/2024 |
OTLK Outlook Therapeutics | $1.99
-2.5% | 10/18/2024 | Reiterated by | BTIG Research | - | Buy -> Buy | $50.00 -> $50.00 | High | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 10/18/2024 |
AURA Aura Biosciences | $7.89
-2.6% | 10/18/2024 | Target Raised by | BTIG Research | Analyst Julian Harrison | Buy -> Buy | $21.00 -> $24.00 | High | View details for BTIG Research rating of Aura Biosciences (NASDAQ:AURA) on 10/18/2024 |
HUMA Humacyte | $4.61
+0.4% | 10/18/2024 | Reiterated by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $10.00 -> $10.00 | High | View details for BTIG Research rating of Humacyte (NASDAQ:HUMA) on 10/18/2024 |
OKTA Okta | $88.86
+0.9% | 10/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $128.00 -> $98.00 | Low | View details for BTIG Research rating of Okta (NASDAQ:OKTA) on 10/17/2024 |
SBUX Starbucks | $98.81
+0.8% | 10/17/2024 | Target Raised by | BTIG Research | Analyst Peter Saleh | Buy -> Buy | $100.00 -> $115.00 | Low | View details for BTIG Research rating of Starbucks (NASDAQ:SBUX) on 10/17/2024 |
INMD InMode | $17.25
-0.1% | 10/17/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Buy | $25.00 | Low | View details for BTIG Research rating of InMode (NASDAQ:INMD) on 10/17/2024 |
APYX Apyx Medical | $1.49
-2.6% | 10/17/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Neutral | | Medium | View details for BTIG Research rating of Apyx Medical (NASDAQ:APYX) on 10/17/2024 |
AIRS AirSculpt Technologies | $5.11
-2.9% | 10/17/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Neutral | | High | View details for BTIG Research rating of AirSculpt Technologies (NASDAQ:AIRS) on 10/17/2024 |
DHT DHT | $10.81
-1.2% | 10/15/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $16.00 | Medium | View details for BTIG Research rating of DHT (NYSE:DHT) on 10/15/2024 |
ESTA Establishment Labs | $32.89
-3.3% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $62.00 -> $65.00 | Low | View details for BTIG Research rating of Establishment Labs (NASDAQ:ESTA) on 10/14/2024 |
GMED Globus Medical | $92.82
+0.4% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $77.00 -> $78.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 10/14/2024 |
PODD Insulet | $280.35
+1.1% | 10/14/2024 | Target Raised by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $250.00 -> $260.00 | Medium | View details for BTIG Research rating of Insulet (NASDAQ:PODD) on 10/14/2024 |
ISRG Intuitive Surgical | $584.05
-4.0% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $494.00 -> $518.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 10/14/2024 |
MASI Masimo | $170.24
+1.3% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $166.00 -> $170.00 | Low | View details for BTIG Research rating of Masimo (NASDAQ:MASI) on 10/14/2024 |
PEN Penumbra | $274.25
+0.2% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $224.00 -> $234.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 10/14/2024 |
SYK Stryker | $394.08
+0.1% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $374.00 -> $383.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 10/14/2024 |
ALC Alcon | $89.02
-0.1% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $104.00 -> $106.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 10/14/2024 |
BSX Boston Scientific | $101.97
+0.3% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $84.00 -> $93.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 10/14/2024 |
CSTL Castle Biosciences | $26.44
-0.2% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $35.00 -> $40.00 | High | View details for BTIG Research rating of Castle Biosciences (NASDAQ:CSTL) on 10/14/2024 |
DPZ Domino's Pizza | $434.23
-3.0% | 10/11/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $580.00 -> $500.00 | Low | View details for BTIG Research rating of Domino’s Pizza (NASDAQ:DPZ) on 10/11/2024 |
FOUR Shift4 Payments | $116.55
-0.8% | 10/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $90.00 -> $105.00 | Medium | View details for BTIG Research rating of Shift4 Payments (NYSE:FOUR) on 10/10/2024 |
BIRK Birkenstock | $59.83
+2.0% | 10/10/2024 | Initiated by | BTIG Research | Analyst J. Stichter | Buy | $60.00 | High | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 10/10/2024 |
CYBR CyberArk Software | $359.72
+0.2% | 10/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $310.00 -> $325.00 | Low | View details for BTIG Research rating of CyberArk Software (NASDAQ:CYBR) on 10/9/2024 |
BLBD Blue Bird | $37.50
-3.7% | 10/9/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $55.00 | High | View details for BTIG Research rating of Blue Bird (NASDAQ:BLBD) on 10/9/2024 |
AXP American Express | $320.87
-1.5% | 10/8/2024 | Downgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Sell | $230.00 | Medium | View details for BTIG Research rating of American Express (NYSE:AXP) on 10/8/2024 |
AFRM Affirm | $55.73
-1.8% | 10/8/2024 | Upgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Buy | $68.00 | High | View details for BTIG Research rating of Affirm (NASDAQ:AFRM) on 10/8/2024 |
IART Integra LifeSciences | $26.05
+1.8% | 10/7/2024 | Upgraded by | BTIG Research | Analyst R. Zimmerman | Sell -> Neutral | | High | View details for BTIG Research rating of Integra LifeSciences (NASDAQ:IART) on 10/7/2024 |
FRO Frontline | $16.01
-5.0% | 10/7/2024 | Upgraded by | BTIG Research | Analyst G. Lewis | Neutral -> Buy | $30.00 | High | View details for BTIG Research rating of Frontline (NYSE:FRO) on 10/7/2024 |
ZBH Zimmer Biomet | $110.78
-0.2% | 10/3/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $134.00 -> $126.00 | Low | View details for BTIG Research rating of Zimmer Biomet (NYSE:ZBH) on 10/3/2024 |
ASTH Astrana Health | $37.10
-2.3% | 10/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $60.00 -> $70.00 | Medium | View details for BTIG Research rating of Astrana Health (NASDAQ:ASTH) on 10/3/2024 |
BTSG BrightSpring Health Services | $22.82
+5.9% | 10/3/2024 | Target Raised by | BTIG Research | Analyst D. Larsen | Buy -> Buy | $15.00 -> $20.00 | Low | View details for BTIG Research rating of BrightSpring Health Services (NASDAQ:BTSG) on 10/3/2024 |
ADPT Adaptive Biotechnologies | $7.99
-1.7% | 10/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $7.00 -> $8.00 | Low | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 10/2/2024 |
NKTR Nektar Therapeutics | $0.88
-1.1% | 9/30/2024 | Reiterated by | BTIG Research | Analyst J. Harrison | Buy | $4.00 | High | View details for BTIG Research rating of Nektar Therapeutics (NASDAQ:NKTR) on 9/30/2024 |
EXPE Expedia Group | $171.23
-3.2% | 9/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $175.00 | Low | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 9/27/2024 |
VRDN Viridian Therapeutics | $18.45
-1.7% | 9/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $56.00 -> $61.00 | Low | View details for BTIG Research rating of Viridian Therapeutics (NASDAQ:VRDN) on 9/26/2024 |
LSPD Lightspeed Commerce | $14.71
+0.1% | 9/26/2024 | Reiterated by | BTIG Research | - | Buy -> Buy | $21.00 -> $21.00 | High | View details for BTIG Research rating of Lightspeed Commerce (NYSE:LSPD) on 9/26/2024 |
Must-See: 5-Second Trump Prediction (Ad) President Trump's prediction is about to become a reality...
Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration. Click here now to get the details because you must act before January 20th. |
GPN Global Payments | $108.92
+1.0% | 9/25/2024 | Downgraded by | BTIG Research | Analyst A. Harte | Buy -> Neutral | | High | View details for BTIG Research rating of Global Payments (NYSE:GPN) on 9/25/2024 |
DRI Darden Restaurants | $187.69
+0.8% | 9/20/2024 | Target Raised by | BTIG Research | Analyst P. Saleh | Buy -> Buy | $175.00 -> $195.00 | Low | View details for BTIG Research rating of Darden Restaurants (NYSE:DRI) on 9/20/2024 |
DASH DoorDash | $183.32
+0.1% | 9/19/2024 | Upgraded by | BTIG Research | Analyst J. Fuller | Neutral -> Buy | $155.00 | Low | View details for BTIG Research rating of DoorDash (NASDAQ:DASH) on 9/19/2024 |
GEHC GE HealthCare Technologies | $88.67
+0.6% | 9/18/2024 | Upgraded by | BTIG Research | Analyst R. Zimmerman | Neutral -> Buy | $100.00 | Low | View details for BTIG Research rating of GE HealthCare Technologies (NASDAQ:GEHC) on 9/18/2024 |
AVAV AeroVironment | $180.36
-0.7% | 9/17/2024 | Reiterated by | BTIG Research | Analyst A. Madrid | Buy -> Buy | $245.00 -> $245.00 | Low | View details for BTIG Research rating of AeroVironment (NASDAQ:AVAV) on 9/17/2024 |
DH Definitive Healthcare | $4.83
-0.8% | 9/17/2024 | Initiated by | BTIG Research | Analyst D. Larsen | Buy | $7.00 | High | View details for BTIG Research rating of Definitive Healthcare (NASDAQ:DH) on 9/17/2024 |
SYF Synchrony Financial | $70.52
+0.1% | 9/16/2024 | Downgraded by | BTIG Research | Analyst V. Caintic | Buy -> Neutral | | Low | View details for BTIG Research rating of Synchrony Financial (NYSE:SYF) on 9/16/2024 |
ALLY Ally Financial | $39.03
-2.7% | 9/16/2024 | Downgraded by | BTIG Research | Analyst V. Caintic | Buy -> Neutral | | Low | View details for BTIG Research rating of Ally Financial (NYSE:ALLY) on 9/16/2024 |
APP AppLovin | $363.10
+0.2% | 9/13/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $114.00 -> $150.00 | High | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 9/13/2024 |
NFE New Fortress Energy | $15.36
-3.5% | 9/13/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $35.00 -> $15.00 | High | View details for BTIG Research rating of New Fortress Energy (NASDAQ:NFE) on 9/13/2024 |
ALC Alcon | $89.02
-0.1% | 9/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $98.00 -> $104.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 9/12/2024 |
RZLT Rezolute | $4.81
-3.6% | 9/10/2024 | Target Raised by | BTIG Research | Analyst J. Harrison | Buy -> Buy | $13.00 -> $15.00 | Low | View details for BTIG Research rating of Rezolute (NASDAQ:RZLT) on 9/10/2024 |
VRDN Viridian Therapeutics | $18.45
-1.7% | 9/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $46.00 -> $56.00 | High | View details for BTIG Research rating of Viridian Therapeutics (NASDAQ:VRDN) on 9/10/2024 |
BOOT Boot Barn | $169.13
+0.4% | 9/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $165.00 | High | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 9/10/2024 |
HAE Haemonetics | $70.61
-3.1% | 9/10/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Buy | $112.00 | Medium | View details for BTIG Research rating of Haemonetics (NYSE:HAE) on 9/10/2024 |
BNGO Bionano Genomics | $0.12
-8.2% | 9/10/2024 | Downgraded by | BTIG Research | Analyst M. Massaro | Buy -> Neutral | | High | View details for BTIG Research rating of Bionano Genomics (NASDAQ:BNGO) on 9/10/2024 |
RBLX Roblox | $67.00
-0.2% | 9/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $47.00 -> $51.00 | High | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 9/9/2024 |
PNST Pinstripes | $0.39
+1.6% | 9/5/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $6.00 -> $4.00 | Low | View details for BTIG Research rating of Pinstripes (NYSE:PNST) on 9/5/2024 |
SOLV Solventum | $74.93
+1.8% | 9/5/2024 | Initiated by | BTIG Research | Analyst R. Zimmerman | Neutral | | Low | View details for BTIG Research rating of Solventum (NYSE:SOLV) on 9/5/2024 |
GTLB GitLab | $64.79
+1.3% | 9/4/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $58.00 -> $63.00 | Low | View details for BTIG Research rating of GitLab (NASDAQ:GTLB) on 9/4/2024 |
ZS Zscaler | $193.47
+0.4% | 9/4/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $220.00 -> $205.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 9/4/2024 |
ATHA Athira Pharma | $0.56
+0.0% | 9/4/2024 | Downgraded by | BTIG Research | Analyst T. Shrader | Buy -> Neutral | | Low | View details for BTIG Research rating of Athira Pharma (NASDAQ:ATHA) on 9/4/2024 |
PCVX Vaxcyte | $89.64
-0.4% | 9/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $98.00 -> $160.00 | Low | View details for BTIG Research rating of Vaxcyte (NASDAQ:PCVX) on 9/3/2024 |
GWRE Guidewire Software | $205.34
+0.4% | 8/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $140.00 -> $165.00 | Low | View details for BTIG Research rating of Guidewire Software (NYSE:GWRE) on 8/30/2024 |
SYK Stryker | $394.08
+0.1% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $360.00 -> $374.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 8/28/2024 |
PEN Penumbra | $274.25
+0.2% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $187.00 -> $224.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 8/28/2024 |
ISRG Intuitive Surgical | $584.05
-4.0% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $469.00 -> $494.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 8/28/2024 |
IART Integra LifeSciences | $26.05
+1.8% | 8/28/2024 | Target Lowered by | BTIG Research | Analyst R. Zimmerman | Sell -> Sell | $22.00 -> $20.00 | Low | View details for BTIG Research rating of Integra LifeSciences (NASDAQ:IART) on 8/28/2024 |
GMED Globus Medical | $92.82
+0.4% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $77.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 8/28/2024 |
GKOS Glaukos | $160.50
-0.4% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $131.00 -> $139.00 | Low | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 8/28/2024 |
S SentinelOne | $23.15
+0.1% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $28.00 -> $30.00 | Low | View details for BTIG Research rating of SentinelOne (NYSE:S) on 8/28/2024 |
FI Fiserv | $208.90
+1.2% | 8/28/2024 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $200.00 | Low | View details for BTIG Research rating of Fiserv (NYSE:FI) on 8/28/2024 |
QTWO Q2 | $94.00
-0.7% | 8/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $82.00 | Low | View details for BTIG Research rating of Q2 (NYSE:QTWO) on 8/26/2024 |
FTAI FTAI Aviation | $90.98
-10.4% | 8/26/2024 | Initiated by | BTIG Research | - | Buy | $80.00 -> $140.00 | Low | View details for BTIG Research rating of FTAI Aviation (NYSE:FTAI) on 8/26/2024 |
DNA Ginkgo Bioworks | $12.76
-3.2% | 8/23/2024 | Target Raised by | BTIG Research | Analyst M. Massaro | Sell -> Sell | $0.20 -> $7.00 | Low | View details for BTIG Research rating of Ginkgo Bioworks (NYSE:DNA) on 8/23/2024 |
ALC Alcon | $89.02
-0.1% | 8/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $96.00 -> $98.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 8/22/2024 |
MELI MercadoLibre | $1,843.45
+0.8% | 8/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $2,025.00 -> $2,250.00 | Low | View details for BTIG Research rating of MercadoLibre (NASDAQ:MELI) on 8/21/2024 |
CCSI Consensus Cloud Solutions | $26.36
+2.1% | 8/21/2024 | Upgraded by | BTIG Research | Analyst D. Larsen | Neutral -> Buy | $30.00 | Low | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 8/21/2024 |
PANW Palo Alto Networks | $187.70
+0.2% | 8/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $183.00 -> $197.50 | Low | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 8/20/2024 |
LQDA Liquidia | $14.36
-0.3% | 8/19/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $29.00 -> $25.00 | Low | View details for BTIG Research rating of Liquidia (NASDAQ:LQDA) on 8/19/2024 |
CDNA CareDx | $22.34
-4.7% | 8/19/2024 | Upgraded by | BTIG Research | Analyst M. Massaro | Neutral -> Buy | $40.00 | Low | View details for BTIG Research rating of CareDx (NASDAQ:CDNA) on 8/19/2024 |
OS Onestream | $30.37
+0.1% | 8/19/2024 | Initiated by | BTIG Research | Analyst M. Vanvliet | Buy | $37.00 | Low | View details for BTIG Research rating of Onestream (NASDAQ:OS) on 8/19/2024 |
TMHC Taylor Morrison Home | $65.47
-1.0% | 8/19/2024 | Upgraded by | BTIG Research | Analyst C. Reichardt | Neutral -> Buy | $78.00 | Low | View details for BTIG Research rating of Taylor Morrison Home (NYSE:TMHC) on 8/19/2024 |
PSNL Personalis | $6.12
-0.5% | 8/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $5.50 -> $7.00 | Low | View details for BTIG Research rating of Personalis (NASDAQ:PSNL) on 8/16/2024 |
RVLV Revolve Group | $31.54
+0.3% | 8/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $24.00 -> $26.00 | Low | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 8/16/2024 |
PYCR Paycor HCM | $22.22
+0.2% | 8/15/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $26.00 -> $20.00 | Low | View details for BTIG Research rating of Paycor HCM (NASDAQ:PYCR) on 8/15/2024 |
FLUT Flutter Entertainment | $267.27
-0.2% | 8/14/2024 | Target Raised by | BTIG Research | Analyst C. Lampen | Buy -> Buy | $245.00 -> $249.00 | Low | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 8/14/2024 |
ENVA Enova International | $111.67
+0.4% | 8/14/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $90.00 | Low | View details for BTIG Research rating of Enova International (NYSE:ENVA) on 8/14/2024 |
ZTS Zoetis | $168.63
+1.0% | 8/12/2024 | Target Raised by | BTIG Research | Analyst M. Massaro | Buy -> Buy | $220.00 -> $225.00 | Low | View details for BTIG Research rating of Zoetis (NYSE:ZTS) on 8/12/2024 |
IRT Independence Realty Trust | $18.80
+0.1% | 8/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $21.00 | Low | View details for BTIG Research rating of Independence Realty Trust (NYSE:IRT) on 8/12/2024 |
Must-See: 5-Second Trump Prediction (Ad) President Trump's prediction is about to become a reality...
Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration. Click here now to get the details because you must act before January 20th. |
CSR Centerspace | $61.07
-0.2% | 8/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $69.00 -> $79.00 | Low | View details for BTIG Research rating of Centerspace (NYSE:CSR) on 8/12/2024 |
ADC Agree Realty | $71.84
+0.5% | 8/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $74.00 | Low | View details for BTIG Research rating of Agree Realty (NYSE:ADC) on 8/12/2024 |
TTD Trade Desk | $119.96
+0.7% | 8/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $114.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 8/9/2024 |
FIVN Five9 | $39.74
+1.6% | 8/9/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $100.00 -> $45.00 | Low | View details for BTIG Research rating of Five9 (NASDAQ:FIVN) on 8/9/2024 |
PODD Insulet | $280.35
+1.1% | 8/9/2024 | Target Lowered by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $270.00 -> $250.00 | Low | View details for BTIG Research rating of Insulet (NASDAQ:PODD) on 8/9/2024 |
CARG CarGurus | $38.93
-1.0% | 8/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $28.00 -> $30.00 | Low | View details for BTIG Research rating of CarGurus (NASDAQ:CARG) on 8/9/2024 |
NTRA Natera | $167.61
-2.5% | 8/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $125.00 -> $135.00 | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 8/9/2024 |
BMBL Bumble | $7.50
| 8/8/2024 | Downgraded by | BTIG Research | Analyst J. Fuller | Buy -> Neutral | | Low | View details for BTIG Research rating of Bumble (NASDAQ:BMBL) on 8/8/2024 |
FLYW Flywire | $19.17
+4.0% | 8/7/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $27.00 -> $26.00 | Low | View details for BTIG Research rating of Flywire (NASDAQ:FLYW) on 8/7/2024 |
BL BlackLine | $60.46
+0.0% | 8/7/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $71.00 -> $65.00 | Low | View details for BTIG Research rating of BlackLine (NASDAQ:BL) on 8/7/2024 |
TRIP Tripadvisor | $17.66
-1.5% | 8/7/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $25.00 -> $20.00 | Low | View details for BTIG Research rating of Tripadvisor (NASDAQ:TRIP) on 8/7/2024 |
IMXI International Money Express | $19.59
-0.2% | 8/7/2024 | Reiterated by | BTIG Research | Analyst A. Harte | Buy -> Neutral | | Low | View details for BTIG Research rating of International Money Express (NASDAQ:IMXI) on 8/7/2024 |
PGNY Progyny | $22.09
+0.3% | 8/7/2024 | Downgraded by | BTIG Research | Analyst D. Larsen | Buy -> Neutral | | Low | View details for BTIG Research rating of Progyny (NASDAQ:PGNY) on 8/7/2024 |
TRUE TrueCar | $3.62
+2.3% | 8/7/2024 | Upgraded by | BTIG Research | Analyst M. Fong | Neutral -> Buy | $3.75 | Low | View details for BTIG Research rating of TrueCar (NASDAQ:TRUE) on 8/7/2024 |
UWMC UWM | $6.15
-0.4% | 8/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $8.00 -> $10.00 | Low | View details for BTIG Research rating of UWM (NYSE:UWMC) on 8/6/2024 |
AKYA Akoya Biosciences | $3.07
-5.0% | 8/6/2024 | Downgraded by | BTIG Research | Analyst M. Massaro | Buy -> Neutral | | Low | View details for BTIG Research rating of Akoya Biosciences (NASDAQ:AKYA) on 8/6/2024 |
MTG MGIC Investment | $24.76
-0.1% | 8/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $22.00 -> $25.00 | Low | View details for BTIG Research rating of MGIC Investment (NYSE:MTG) on 8/5/2024 |
ACT Enact | $33.20
-0.2% | 8/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $33.00 -> $37.00 | N/A | View details for BTIG Research rating of Enact (NASDAQ:ACT) on 8/5/2024 |
ESNT Essent Group | $57.54
-0.3% | 8/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $61.00 -> $64.00 | Low | View details for BTIG Research rating of Essent Group (NYSE:ESNT) on 8/5/2024 |
HWM Howmet Aerospace | $126.99
-0.6% | 8/5/2024 | Target Raised by | BTIG Research | Analyst A. Madrid | Buy -> Buy | $95.00 -> $115.00 | Low | View details for BTIG Research rating of Howmet Aerospace (NYSE:HWM) on 8/5/2024 |
MELI MercadoLibre | $1,843.45
+0.8% | 8/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $1,885.00 -> $2,025.00 | Low | View details for BTIG Research rating of MercadoLibre (NASDAQ:MELI) on 8/2/2024 |
PCTY Paylocity | $206.50
+1.5% | 8/2/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $200.00 -> $185.00 | Low | View details for BTIG Research rating of Paylocity (NASDAQ:PCTY) on 8/2/2024 |
VEL Velocity Financial | $18.40
-0.1% | 8/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $20.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 8/2/2024 |
SMRT SmartRent | $1.59
+0.3% | 8/2/2024 | Downgraded by | BTIG Research | Analyst S. Bhonsle | Buy -> Neutral | | Low | View details for BTIG Research rating of SmartRent (NYSE:SMRT) on 8/2/2024 |
CVNA Carvana | $240.74
-1.0% | 8/1/2024 | Target Raised by | BTIG Research | Analyst M. Fong | Buy -> Buy | $155.00 -> $188.00 | Low | View details for BTIG Research rating of Carvana (NYSE:CVNA) on 8/1/2024 |
DRS Leonardo DRS | $36.81
-1.6% | 8/1/2024 | Target Raised by | BTIG Research | Analyst A. Madrid | Buy -> Buy | $30.00 -> $33.00 | Low | View details for BTIG Research rating of Leonardo DRS (NASDAQ:DRS) on 8/1/2024 |
QTWO Q2 | $94.00
-0.7% | 8/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $60.00 -> $75.00 | Low | View details for BTIG Research rating of Q2 (NYSE:QTWO) on 8/1/2024 |
MGNX MacroGenics | $3.23
+2.2% | 8/1/2024 | Downgraded by | BTIG Research | Analyst K. Pohlman | Buy -> Neutral | | Low | View details for BTIG Research rating of MacroGenics (NASDAQ:MGNX) on 8/1/2024 |
DDOG Datadog | $140.99
+0.6% | 8/1/2024 | Upgraded by | BTIG Research | Analyst G. Powell | Neutral -> Buy | $143.00 | Low | View details for BTIG Research rating of Datadog (NASDAQ:DDOG) on 8/1/2024 |
WGS GeneDx | $79.27
+2.1% | 7/31/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $35.00 -> $45.00 | Low | View details for BTIG Research rating of GeneDx (NASDAQ:WGS) on 7/31/2024 |
ATRC AtriCure | $40.58
+0.5% | 7/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $58.00 -> $53.00 | Low | View details for BTIG Research rating of AtriCure (NASDAQ:ATRC) on 7/31/2024 |
PEN Penumbra | $274.25
+0.2% | 7/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $232.00 -> $187.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 7/31/2024 |
SYK Stryker | $394.08
+0.1% | 7/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $372.00 -> $360.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 7/31/2024 |
AOMR Angel Oak Mortgage REIT | $10.14
+0.7% | 7/31/2024 | Initiated by | BTIG Research | Analyst E. Hagen | Buy | $13.50 | Low | View details for BTIG Research rating of Angel Oak Mortgage REIT (NYSE:AOMR) on 7/31/2024 |
GH Guardant Health | $47.21
-2.9% | 7/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $45.00 -> $50.00 | Low | View details for BTIG Research rating of Guardant Health (NASDAQ:GH) on 7/30/2024 |
CRS Carpenter Technology | $210.59
-0.9% | 7/30/2024 | Target Raised by | BTIG Research | Analyst A. Madrid | Buy -> Buy | $120.00 -> $165.00 | Low | View details for BTIG Research rating of Carpenter Technology (NYSE:CRS) on 7/30/2024 |
IART Integra LifeSciences | $26.05
+1.8% | 7/30/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Neutral -> Sell | $22.00 | Low | View details for BTIG Research rating of Integra LifeSciences (NASDAQ:IART) on 7/30/2024 |
TXRH Texas Roadhouse | $178.55
-0.3% | 7/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $175.00 -> $190.00 | Low | View details for BTIG Research rating of Texas Roadhouse (NASDAQ:TXRH) on 7/26/2024 |
TYL Tyler Technologies | $591.97
-0.3% | 7/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $550.00 -> $630.00 | Low | View details for BTIG Research rating of Tyler Technologies (NYSE:TYL) on 7/26/2024 |
DXCM DexCom | $88.75
+1.2% | 7/26/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $156.00 -> $120.00 | Low | View details for BTIG Research rating of DexCom (NASDAQ:DXCM) on 7/26/2024 |
ZTS Zoetis | $168.63
+1.0% | 7/25/2024 | Initiated by | BTIG Research | Analyst M. Massaro | Buy | $220.00 | Low | View details for BTIG Research rating of Zoetis (NYSE:ZTS) on 7/25/2024 |
IDXX IDEXX Laboratories | $435.33
+0.7% | 7/25/2024 | Initiated by | BTIG Research | Analyst M. Massaro | Buy | $580.00 | Low | View details for BTIG Research rating of IDEXX Laboratories (NASDAQ:IDXX) on 7/25/2024 |
PTGX Protagonist Therapeutics | $37.69
-0.3% | 7/24/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $41.00 -> $51.00 | Low | View details for BTIG Research rating of Protagonist Therapeutics (NASDAQ:PTGX) on 7/24/2024 |
PHM PulteGroup | $115.66
-0.7% | 7/24/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $133.00 -> $139.00 | Low | View details for BTIG Research rating of PulteGroup (NYSE:PHM) on 7/24/2024 |
EXPI eXp World | $11.10
+0.3% | 7/23/2024 | Upgraded by | BTIG Research | Analyst S. Bhonsle | Sell -> Neutral | | Low | View details for BTIG Research rating of eXp World (NASDAQ:EXPI) on 7/23/2024 |
STC Stewart Information Services | $64.34
+0.6% | 7/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $68.00 -> $80.00 | Low | View details for BTIG Research rating of Stewart Information Services (NYSE:STC) on 7/22/2024 |
CRWD CrowdStrike | $374.92
-0.7% | 7/22/2024 | Downgraded by | BTIG Research | Analyst G. Powell | Buy -> Neutral | | Low | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 7/22/2024 |
AGYS Agilysys | $92.24
-3.6% | 7/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $95.00 -> $118.00 | Low | View details for BTIG Research rating of Agilysys (NASDAQ:AGYS) on 7/19/2024 |
FOR Forestar Group | $23.46
-3.2% | 7/19/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $41.00 -> $37.00 | Low | View details for BTIG Research rating of Forestar Group (NYSE:FOR) on 7/19/2024 |
ARI Apollo Commercial Real Estate Finance | $8.95
+0.7% | 7/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Apollo Commercial Real Estate Finance (NYSE:ARI) on 7/19/2024 |
CMTG Claros Mortgage Trust | $3.52
+1.0% | 7/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Claros Mortgage Trust (NYSE:CMTG) on 7/19/2024 |
RC Ready Capital | $6.82
-0.1% | 7/19/2024 | Initiated by | BTIG Research | Analyst S. Barcomb | Strong-Buy -> Neutral | | Low | View details for BTIG Research rating of Ready Capital (NYSE:RC) on 7/19/2024 |
ACRE Ares Commercial Real Estate | $5.76
+1.3% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Neutral | | Low | View details for BTIG Research rating of Ares Commercial Real Estate (NYSE:ACRE) on 7/19/2024 |
BRSP BrightSpire Capital | $5.60
+0.4% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Neutral | | Low | View details for BTIG Research rating of BrightSpire Capital (NYSE:BRSP) on 7/19/2024 |
BXMT Blackstone Mortgage Trust | $17.78
+1.0% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $23.00 | Low | View details for BTIG Research rating of Blackstone Mortgage Trust (NYSE:BXMT) on 7/19/2024 |
FBRT Franklin BSP Realty Trust | $12.47
+0.9% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $16.00 | Low | View details for BTIG Research rating of Franklin BSP Realty Trust (NYSE:FBRT) on 7/19/2024 |
KREF KKR Real Estate Finance Trust | $10.08
-0.3% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $11.50 | Low | View details for BTIG Research rating of KKR Real Estate Finance Trust (NYSE:KREF) on 7/19/2024 |
LADR Ladder Capital | $11.07
+0.2% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $13.50 | Low | View details for BTIG Research rating of Ladder Capital (NYSE:LADR) on 7/19/2024 |
STWD Starwood Property Trust | $19.19
+0.8% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $24.00 | Low | View details for BTIG Research rating of Starwood Property Trust (NYSE:STWD) on 7/19/2024 |
TRTX TPG RE Finance Trust | $8.36
+0.7% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $11.00 | Low | View details for BTIG Research rating of TPG RE Finance Trust (NYSE:TRTX) on 7/19/2024 |
